
ActX helps physicians make better treatment decisions, using patients' genetics, within CGM APRIMA.
ActX brings precision medicine based on genomics to day-to-day patient care for CGM APRIMA users. It is closely integrated with CGM APRIMA, frequently updated based on the latest research, and designed for the busy clinician who is not an expert in genetics.
ActX focuses on actionable genomics, where there are clear evidence-based actions for physicians and patients to take.
ActX is a complete service. After an order is placed, ActX takes care of obtaining patient genetic data through affordable saliva-based genetic testing. ActX analyzes a genome in real time and alerts physicians about drug-genome interactions, actionable serious hereditary risks, and carrier status. Every time a prescription is written in CGM APRIMA, ActX checks the drug against the patient's genetics, providing an alert if there is an issue with medication efficacy, dosing, or adverse effects. ActX provides seamless workflow for the busy clinician.
ActX tests for drug genomic interactions for over 500 commonly prescribed medications
ActX tests for over 80 actionable hereditary disease risks, including:
ActX tests for over 230 carrier statuses
The information you and your patients receive is never out of date
ActX staffs world-class scientists and university advisors to deliver the actionable, evidence-based information you need in a format you can trust
Good candidates for ActX genetic testing include, but are not limited to: